A mycosis affecting the skin, mucous membranes, lymph nodes, and internal organs. It is caused by Paracoccidioides brasiliensis. It is also called paracoccidioidal granuloma. Superficial resemblance of P. brasiliensis to Blastomyces brasiliensis (BLASTOMYCES) may cause misdiagnosis.
A mitosporic fungal genus. P. brasiliensis (previously Blastomyces brasiliensis) is the etiologic agent of PARACOCCIDIOIDOMYCOSIS.
Immunoglobulins produced in a response to FUNGAL ANTIGENS.
Substances of fungal origin that have antigenic activity.
Pulmonary diseases caused by fungal infections, usually through hematogenous spread.
A fungal infection that may appear in two forms: 1, a primary lesion characterized by the formation of a small cutaneous nodule and small nodules along the lymphatics that may heal within several months; and 2, chronic granulomatous lesions characterized by thick crusts, warty growths, and unusual vascularity and infection in the middle or upper lobes of the lung.
A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.
Lip diseases refer to various medical conditions that primarily affect the lips, causing symptoms such as inflammation, pain, dryness, discoloration, or abnormal growths, which may result from infectious, autoimmune, genetic, traumatic, or neoplastic causes.
A group of corticosteroids bearing a hydroxy group at the 11-position.
Histoplasmin is an antigen extracted from the histoplasmoma fungus (Histoplasma capsulatum), used in skin tests to detect previous exposure or infection to this pathogen that causes histoplasmosis.
MYCOSES of the brain, spinal cord, and meninges which may result in ENCEPHALITIS; MENINGITIS, FUNGAL; MYELITIS; BRAIN ABSCESS; and EPIDURAL ABSCESS. Certain types of fungi may produce disease in immunologically normal hosts, while others are classified as opportunistic pathogens, causing illness primarily in immunocompromised individuals (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME).
The body of a fungus which is made up of HYPHAE.
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.
'Gingival diseases' is a general term for conditions affecting the soft tissues surrounding and supporting the teeth, primarily characterized by inflammation, bleeding, redness, or swelling, which can progress to periodontal disease if left untreated.
'Mouth diseases' is a broad term referring to various conditions that cause inflammation, infection, or structural changes in any part of the mouth, including the lips, gums, tongue, palate, cheeks, and teeth, which can lead to symptoms such as pain, discomfort, difficulty in chewing or speaking, and altered aesthetics.
Suspensions of attenuated or killed fungi administered for the prevention or treatment of infectious fungal disease.
Infection resulting from inhalation or ingestion of spores of the fungus of the genus HISTOPLASMA, species H. capsulatum. It is worldwide in distribution and particularly common in the midwestern United States. (From Dorland, 27th ed)
Burrowing, chiefly nocturnal mammals of the family Dasypodidae having bodies and heads encased in small bony plates. They are widely distributed in the warmer parts of the Americas.
I'm sorry for any confusion, but "Brazil" is not a medical term or concept, it is a country located in South America, known officially as the Federative Republic of Brazil. If you have any questions related to health, medicine, or science, I'd be happy to help answer those!
The study of the structure, growth, function, genetics, and reproduction of fungi, and MYCOSES.
An order of fungi in the phylum ASCOMYCOTA containing many medically important species. There are four families and mitosporic (anamorphic) forms are prominent.
Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction.
A large and heterogenous group of fungi whose common characteristic is the absence of a sexual state. Many of the pathogenic fungi in humans belong to this group.
Infection with a fungus of the genus COCCIDIOIDES, endemic to the SOUTHWESTERN UNITED STATES. It is sometimes called valley fever but should not be confused with RIFT VALLEY FEVER. Infection is caused by inhalation of airborne, fungal particles known as arthroconidia, a form of FUNGAL SPORES. A primary form is an acute, benign, self-limited respiratory infection. A secondary form is a virulent, severe, chronic, progressive granulomatous disease with systemic involvement. It can be detected by use of COCCIDIOIDIN.

Endemic mycoses: a treatment update. (1/324)

Endemic mycoses remain a major public health problem in several countries and they are becoming increasingly frequent with the spread of HIV infection. Amphotericin B remains the drug of choice during the acute stage of life-threatening endemic mycoses occurring in both immunocompetent and immunocompromised hosts. Ketoconazole is effective in non-AIDS patients with non-life-threatening histoplasmosis, blastomycosis, or paracoccidioidomycosis. Itraconazole is the treatment of choice for non-life-threatening Histoplasma capsulatum or Blastomyces dermatitidis infections occurring in immunocompetent individuals and is the most efficient secondary prophylaxis of histoplasmosis in AIDS patients. Itraconazole is also effective in lymphocutaneous and visceral sporotrichosis, in paracoccidioidomycosis, for Penicillum marneffei infection, and is an alternative to amphotericin B for Histoplasma duboisii infection. Coccidioidomycosis may be effectively treated with prolonged and sometimes life-long itraconazole or fluconazole therapy. Fluconazole has relatively poor efficacy against histoplasmosis, blastomycosis and sporotrichosis. New antifungal agents have been tested in vitro or in animal models and may soon be evaluated in clinical trials.  (+info)

Lacazia loboi gen. nov., comb. nov., the etiologic agent of lobomycosis. (2/324)

The new genus Lacazia P. Taborda, V. Taborda, et McGinnis is proposed to accommodate Lacazia loboi (O. M. Fonseca et Lacaz) P. Taborda, V. Taborda, et McGinnis, the obligate pathogen that causes lobomycosis in mammals. The continued placement of that fungus in the genus Paracoccidioides Almeida as Paracoccidioides loboi is taxonomically inappropriate. Loboa loboi Ciferri et al. is a synonym of Paracoccidioides brasiliensis.  (+info)

Failure of amphotericin B colloidal dispersion in the treatment of paracoccidioidomycosis. (3/324)

Although amphotericin B desoxycholate is considered the most effective treatment for disseminated Paracoccidioides brasiliensis infections, little is known about the efficacy of lipid-based formulations of amphotericin B in this infection. In this study, we treated four adults with the juvenile form of paracoccidioidomycosis with 3 mg/kg/day of amphotericin B colloidal dispersion for at least 28 days. Although all of the patients initially responded by clinical observation, all four patients relapsed within six months. The use of amphotericin B colloidal dispersion for the initial induction of paracoccidioidomycosis failed to cure this infection. Possible reasons for failure include dose, duration, or reduced efficacy of this lipid preparation. For many fungal infections, lipid-based preparations have been shown to have a therapeutic-toxic advantage, but our experience with Paracoccidioides infections suggests that more careful studies will need to be performed before they can be recommended for use in this mycosis.  (+info)

Macrophage expression of class II major histocompatibility complex gene products in Paracoccidioides brasiliensis-infected mice. (4/324)

C57B1/6 isogenic mice infected with Paracoccidioides brasiliensis strains showed a disruption in the expression of Ia antigen. Expression slowly decreased during the course of the infection with a slight variation dependent on the route of inoculation and the fungal strain used, but production of interferon-gamma and tumor necrosis factor-alpha were observed. Suppression of Ia antigen expression and depression of the immunoproliferative responses of spleen cells were strongly correlated with nitric oxide levels. These parameters were inhibited when the animals were treated with nitro-L-arginine, which resulted in inhibition the activation of nitric oxide (NO) production. Analysis of the data showed that changes in the expression of the Ia antigen occur in P. brasiliensis infection and are strongly correlated with NO levels. These phenomena may be interrelated and reflect macrophage activation that contributes to the control of the disease and to the immunosuppression observed during the course of the infection.  (+info)

Endemic regions of paracoccidioidomycosis in Brazil: a clinical and epidemiologic study of 584 cases in the southeast region. (5/324)

This paper describes the clinical-seroepidemiologic characteristics of patients with paracoccidioidomycosis (PCM) who visited the University Hospital at the State University of Campinas (Campinas, Sao Paulo, Brazil). The study group consisted of 584 individuals (492 males and 92 females) with ages ranging from 5 to 87 years. The highest incidence of the disease occurred between the ages of 41 and 50 years for men and between 11 and 40 years for women. Rural activities were the principal occupation of 46% of the patients. The diagnosis was confirmed by histopathologic examination and demonstration of fungus in scrapings, secretions, or in the sputum. Serologic test results for PCM were positive in 80% of the 584 patients studied. The significant number of patients, including 33 children less than 14 years old, indicates the presence of the fungus in the area and that this region is an important endemic area for PCM.  (+info)

Paracoccidioides brasilienses isolates obtained from patients with acute and chronic disease exhibit morphological differences after animal passage. (6/324)

The basis for virulence in Paracoccidioides brasiliensis is not completely understood. There is a consensus that the sequential in vitro subcultivation of P. brasiliensis leads to loss of its pathogenicity, which can be reverted by reisolation from animal passage. Attention to morphological and biochemical properties that are regained or demonstrated after animal passage may provide new insights into factors related to the pathogenicity and virulence of P. brasiliensis. We evaluated morphological characters: the percentage of budding cells, number of buds by cell and the diameter of 100 mother cells of yeast-like cells of 30 P. brasiliensis isolates, before and after animal passage. The isolates were obtained from patients with different clinical forms of paracoccidioidomycosis (PCM): acute form (group A, n=15) and chronic form (group C, n=15). The measurement of the yeast cell sizes was carried out with the aid of an Olympus CBB microscope coupled with a micrometer disc. We measured the major transverse and longitudinal axes of 100 viable cells of each preparation. The percentage of budding cells as also the number of buds by cell was not influenced by animal passage, regardless of the source of the strain (acute or chronic groups). The size values of P. brasiliensis isolates from groups A and C, measured before the animal passage exhibited the same behavior. After animal passage, there was a statistically significant difference between the cell sizes of P. brasiliensis isolates recovered from testicles inoculated with strains from groups A and C. The maximum diameter of mother cells from group A isolates exhibited a size of 42.1 microm in contrast with 32.9 microm exhibited by mother cells from group C (p<0.05). The diameter of 1500 mother cells from group A isolates exhibited a medium size of 16.0 microm (SD +/- 4.0), a value significantly higher than the 14.1 microm (SD = +/- 3.3) exhibited by 1500 mother cells from group C isolates (p<0.05). Our results reinforce the polymorphism exhibited by P. brasiliensis in biological material and the need for further investigations to elucidate the role of morphological parameters of the fungus in the natural history of the disease.  (+info)

Depletion of CD8(+) T cells in vivo impairs host defense of mice resistant and susceptible to pulmonary paracoccidioidomycosis. (7/324)

Using a pulmonary model of infection, we demonstrated previously that A/Sn and B10.A mice are, respectively, resistant and susceptible to Paracoccidioides brasiliensis infection. Employing the same experimental model, we examined herein the role of CD8(+) T cells in the course of paracoccidioidomycosis. Treatment with anti-CD8 monoclonal antibodies caused a selective depletion of pulmonary and splenic CD8(+) T cells in both mouse strains. The number of pulmonary CD4(+) T cells and immunoglobulin-positive cells was independent of the number of CD8(+) T cells. In susceptible mice, the loss of CD8(+) T cells by in vivo treatment with anti-CD8 monoclonal antibodies impaired the clearance of yeasts from the lungs and increased the fungal dissemination to the liver and spleen. The same treatment in resistant mice increased fungal dissemination to extrapulmonary tissues but did not alter the pulmonary fungal load. Furthermore, CD8(+) T-cell depletion did not modify delayed-type hypersensitivity reactions of A/Sn mice but increased these reactions in B10.A mice. The production of P. brasiliensis-specific antibodies by resistant and susceptible mice depleted of CD8(+) T cells was similar to that of mice given control antibody. Histopathologically, depletion of CD8(+) T cells did not disorganize the focal granulomatous lesions developed by both mouse strains. These results indicate that CD8(+) T cells are necessary for optimal clearance of the fungus from tissues of mice infected with P. brasiliensis and demonstrate more prominent protective activity by those cells in the immune responses mounted by susceptible animals.  (+info)

Evaluation of tests for antibody response in the follow-up of patients with acute and chronic forms of paracoccidioidomycosis. (8/324)

Several serological tests have been used successfully in the diagnosis of paracoccidioidomycosis (PCM). In contrast, data about the use of these tests in the follow-up of PCM patients have been heterogeneous. In this study, serum samples from 43 PCM patients with different clinical forms were analysed by counter-immuno-electrophoresis (CIE), complement fixation (CF) and ELISA before treatment. With CIE and ELISA, the chronic unifocal form showed significantly lower antibody levels compared with chronic multifocal and acute forms. Acute form patients had significantly higher titres than patients with multifocal disease by CIE but not by ELISA. No significant differences were observed with CF. Twenty-seven of these patients were followed-up for 2 years and showed a decline in antibody levels by all three tests, paralleling clinical improvement. However, only patients with unifocal disease cleared their antibodies after 1 year of treatment as analysed by CF and ELISA and after 2 years by CIE, suggesting that these patients may need shorter courses of therapy. Patients with the other clinical form of the disease needed > or =2 years of therapy to clear their antibodies. Sera from a further five patients who presented with a relapse were analysed. At the time of relapse all showed increases in antibody levels by CIE and ELISA, but only three showed increases by CF tests. Therefore, CIE and ELISA demonstrated a better clinical correlation than CF, probably reflecting the fungal burden of PCM patients more accurately.  (+info)

Paracoccidioidomycosis is a deep fungal infection caused by the dimorphic fungus Paracoccidioides brasiliensis, which is endemic in certain regions of Central and South America. The infection primarily affects the lungs but can disseminate to other organs such as the lymph nodes, mucous membranes, skin, and central nervous system.

The disease typically manifests in two clinical forms: acute/subacute (also known as juvenile) and chronic. The acute form tends to occur in younger individuals and is characterized by widespread dissemination of the fungus throughout the body, often leading to severe symptoms and a higher mortality rate. The chronic form, on the other hand, typically affects adult males and presents with pulmonary lesions and slow-growing granulomatous skin or mucosal ulcers.

Diagnosis of paracoccidioidomycosis is usually made by identifying the characteristic "pilot's wheel" or "Mickey Mouse ear" shaped yeast cells in tissue samples, sputum, or other bodily fluids using direct examination, culture, or histopathological methods. Treatment typically involves antifungal therapy with medications such as trimethoprim-sulfamethoxazole, itraconazole, or amphotericin B, depending on the severity and extent of infection.

"Paracoccidioides" is a genus of fungi that includes several species that can cause a human disease known as paracoccidioidomycosis or South American blastomycosis. This disease is acquired by inhaling the spores of the fungus, which are typically found in soil. The most common species associated with the disease is Paracoccidioides brasiliensis.

The fungi in this genus are characterized by their ability to grow as both budding yeast and filamentous forms. In the yeast form, the cells are typically round or oval and have a distinctive "pilot's wheel" or "Mickey Mouse ear" appearance due to the presence of multiple buds radiating from a central point.

Paracoccidioidomycosis is a systemic mycosis that primarily affects the lungs, but can also spread to other organs such as the skin, mucous membranes, lymph nodes, and brain. The disease is more commonly found in rural areas of Latin America, particularly in Brazil, Colombia, and Venezuela. It typically occurs in adults who have been exposed to the fungus for many years, often through agricultural or occupational activities.

The diagnosis of paracoccidioidomycosis is usually made by identifying the characteristic yeast forms of the fungus in clinical specimens such as sputum or tissue biopsies. Treatment typically involves the use of antifungal medications, such as amphotericin B or itraconazole, for several months to a year or more, depending on the severity and extent of the disease.

Fungal antibodies are a type of protein called immunoglobulins that are produced by the immune system in response to the presence of fungi in the body. These antibodies are specifically designed to recognize and bind to antigens on the surface of fungal cells, marking them for destruction by other immune cells.

There are several types of fungal antibodies, including IgA, IgG, IgM, and IgE, each with a specific role in the immune response. For example, IgG antibodies are the most common type of antibody found in the blood and provide long-term immunity to fungi, while IgE antibodies are associated with allergic reactions to fungi.

Fungal antibodies can be measured in the blood or other bodily fluids to help diagnose fungal infections, monitor the effectiveness of treatment, or assess immune function in individuals who are at risk for fungal infections, such as those with weakened immune systems due to HIV/AIDS, cancer, or organ transplantation.

Fungal antigens are substances found on or produced by fungi that can stimulate an immune response in a host organism. They can be proteins, polysaccharides, or other molecules that are recognized as foreign by the host's immune system. Fungal antigens can be used in diagnostic tests to identify fungal infections, and they can also be targets of immune responses during fungal infections. In some cases, fungal antigens may contribute to the pathogenesis of fungal diseases by inducing inflammatory or allergic reactions. Examples of fungal antigens include the cell wall components of Candida albicans and the extracellular polysaccharide galactomannan produced by Aspergillus fumigatus.

Fungal lung diseases, also known as fungal pneumonia or mycoses, refer to a group of respiratory disorders caused by the infection of fungi in the lungs. These fungi are commonly found in the environment, such as soil, decaying organic matter, and contaminated materials. People can develop lung diseases from fungi after inhaling spores or particles that contain fungi.

There are several types of fungal lung diseases, including:

1. Aspergillosis: This is caused by the Aspergillus fungus and can affect people with weakened immune systems. It can cause allergic reactions, lung infections, or invasive aspergillosis, which can spread to other organs.
2. Cryptococcosis: This is caused by the Cryptococcus fungus and is usually found in soil contaminated with bird droppings. It can cause pneumonia, meningitis, or skin lesions.
3. Histoplasmosis: This is caused by the Histoplasma capsulatum fungus and is commonly found in the Ohio and Mississippi River valleys. It can cause flu-like symptoms, lung infections, or disseminated histoplasmosis, which can spread to other organs.
4. Blastomycosis: This is caused by the Blastomyces dermatitidis fungus and is commonly found in the southeastern and south-central United States. It can cause pneumonia, skin lesions, or disseminated blastomycosis, which can spread to other organs.
5. Coccidioidomycosis: This is caused by the Coccidioides immitis fungus and is commonly found in the southwestern United States. It can cause flu-like symptoms, lung infections, or disseminated coccidioidomycosis, which can spread to other organs.

Fungal lung diseases can range from mild to severe, depending on the type of fungus and the person's immune system. Treatment may include antifungal medications, surgery, or supportive care. Prevention measures include avoiding exposure to contaminated soil or dust, wearing protective masks in high-risk areas, and promptly seeking medical attention if symptoms develop.

Blastomycosis is a fungal infection caused by the inhalation of spores of the fungus Blastomyces dermatitidis. It primarily affects the lungs but can also spread to other parts of the body, such as the skin, bones, and central nervous system. The initial symptoms of blastomycosis may include cough, fever, chest pain, and difficulty breathing. If left untreated, the infection can become severe and potentially life-threatening. Treatment typically involves antifungal medications, such as itraconazole or amphotericin B.

Itraconazole is an antifungal medication used to treat various fungal infections, including blastomycosis, histoplasmosis, aspergillosis, and candidiasis. It works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes, thereby disrupting the integrity and function of these membranes. Itraconazole is available in oral and intravenous forms for systemic use and as a topical solution or cream for localized fungal infections.

Medical Definition:
Itraconazole (i-tra-KON-a-zole): A synthetic triazole antifungal agent used to treat various fungal infections, such as blastomycosis, histoplasmosis, aspergillosis, and candidiasis. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes, leading to disruption of their integrity and function. Itraconazole is available in oral (capsule and solution) and intravenous forms for systemic use and as a topical solution or cream for localized fungal infections.

Lip diseases refer to various medical conditions that affect the lips, which can be caused by different factors such as infections, inflammation, allergies, or autoimmune disorders. Some examples of lip diseases include:

1. Cheilitis: It is an inflammation of the lips, which can cause dryness, cracking, and soreness. It can be caused by various factors, including irritants, allergies, or infections.
2. Angular cheilitis: It is a condition that causes inflammation and redness at the corners of the mouth. It can be caused by fungal or bacterial infections, ill-fitting dentures, or vitamin deficiencies.
3. Herpes simplex labialis: Also known as cold sores, it is a viral infection that causes painful blisters on the lips and around the mouth. The virus can be spread through close contact with an infected person.
4. Actinic cheilitis: It is a precancerous condition caused by excessive exposure to the sun, which leads to dry, scaly, or thickened patches on the lips.
5. Fordyce spots: These are small, painless, white or yellowish bumps that appear on the lips and inside the mouth. They are harmless and do not require treatment.
6. Lip cancer: It is a type of skin cancer that affects the lips, usually caused by excessive exposure to the sun. The symptoms include a sore or lump on the lip that does not heal, bleeding, pain, or numbness.

If you experience any symptoms related to lip diseases, it is recommended to consult a healthcare professional for proper diagnosis and treatment.

11-Hydroxycorticosteroids are a class of steroid hormones that are produced in the adrenal gland. They are created when cortisol, a type of glucocorticoid hormone, is metabolized by the enzyme 11-beta-hydroxysteroid dehydrogenase type 2 (11-β-HSD2) in the kidneys. This results in the formation of cortisone, which is then converted back to cortisol as needed.

11-Hydroxycorticosteroids are important for regulating a variety of physiological processes, including metabolism, immune response, and stress response. They also have anti-inflammatory effects and are sometimes used in medical treatments to reduce inflammation and suppress the immune system.

Elevated levels of 11-hydroxycorticosteroids can indicate an overactive adrenal gland or a tumor that is producing excess cortisol. Low levels may be seen in conditions such as Addison's disease, which is characterized by underactivity of the adrenal gland.

Medical definitions of 11-hydroxycorticosteroids typically refer to the measurement of these hormones in urine or blood tests, which can help diagnose and monitor various medical conditions.

Histoplasmin is not a medical condition or diagnosis itself, but it's a term related to a skin test used in medicine. Histoplasmin is an antigen extract derived from the histoplasmoma (a form of the fungus Histoplasma capsulatum) used in the histoplasmin skin test. This test is utilized to determine whether a person has been infected with the histoplasmosis fungus, which causes the disease histoplasmosis.

The histoplasmin skin test involves injecting a small amount of histoplasmin under the surface of the skin, usually on the forearm. If the person has previously been exposed to Histoplasma capsulatum, their immune system will recognize the antigen and produce a reaction (a hard, red, swollen area) at the injection site within 24-72 hours. The size of this reaction helps healthcare professionals determine if the person has developed an immune response to the fungus, indicating past or current infection with histoplasmosis.

It's important to note that a positive histoplasmin skin test does not necessarily mean that the person is currently sick with histoplasmosis. Instead, it shows that they have been exposed to the fungus at some point in their life and have developed an immune response to it.

Central nervous system (CNS) fungal infections refer to invasive fungal diseases that affect the brain and/or spinal cord. These types of infections are relatively uncommon but can be serious and potentially life-threatening, especially in individuals with weakened immune systems due to conditions such as HIV/AIDS, cancer, or organ transplantation.

There are several types of fungi that can cause CNS infections, including:

1. Candida species: These are yeast-like fungi that can cause a range of infections, from superficial to systemic. When they invade the CNS, they can cause meningitis or brain abscesses.
2. Aspergillus species: These are mold-like fungi that can cause invasive aspergillosis, which can affect various organs, including the brain.
3. Cryptococcus neoformans: This is a yeast-like fungus that primarily affects people with weakened immune systems. It can cause meningitis or brain abscesses.
4. Coccidioides species: These are mold-like fungi that can cause coccidioidomycosis, also known as Valley Fever. While most infections are limited to the lungs, some people may develop disseminated disease, which can affect the CNS.
5. Histoplasma capsulatum: This is a mold-like fungus that causes histoplasmosis, which primarily affects the lungs but can disseminate and involve the CNS.

Symptoms of CNS fungal infections may include headache, fever, altered mental status, seizures, stiff neck, and focal neurologic deficits. Diagnosis typically involves a combination of clinical evaluation, imaging studies (such as MRI or CT), and laboratory tests (such as cerebrospinal fluid analysis or fungal cultures). Treatment usually involves long-term antifungal therapy, often with a combination of drugs, and may also include surgical intervention in some cases.

Mycelium is not a specifically medical term, but it is a biological term used in fungi and other organisms. Medically, it might be relevant in certain contexts such as discussing fungal infections. Here's the general definition:

Mycelium (my-SEE-lee-um) is the vegetative part of a fungus, consisting of a mass of branching, thread-like hyphae. It is the underground portion of the fungus that supports the growth of the organism and is often responsible for the decomposition of organic material. Mycelium can be found in various environments, including soil, water, and dead or living organisms.

Antifungal agents are a type of medication used to treat and prevent fungal infections. These agents work by targeting and disrupting the growth of fungi, which include yeasts, molds, and other types of fungi that can cause illness in humans.

There are several different classes of antifungal agents, including:

1. Azoles: These agents work by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. Examples of azole antifungals include fluconazole, itraconazole, and voriconazole.
2. Echinocandins: These agents target the fungal cell wall, disrupting its synthesis and leading to fungal cell death. Examples of echinocandins include caspofungin, micafungin, and anidulafungin.
3. Polyenes: These agents bind to ergosterol in the fungal cell membrane, creating pores that lead to fungal cell death. Examples of polyene antifungals include amphotericin B and nystatin.
4. Allylamines: These agents inhibit squalene epoxidase, a key enzyme in ergosterol synthesis. Examples of allylamine antifungals include terbinafine and naftifine.
5. Griseofulvin: This agent disrupts fungal cell division by binding to tubulin, a protein involved in fungal cell mitosis.

Antifungal agents can be administered topically, orally, or intravenously, depending on the severity and location of the infection. It is important to use antifungal agents only as directed by a healthcare professional, as misuse or overuse can lead to resistance and make treatment more difficult.

Gingival diseases are infections or inflammations that affect the gingiva, which is the part of the gum around the base of the teeth. These diseases can be caused by bacteria found in dental plaque and can lead to symptoms such as redness, swelling, bleeding, and receding gums. If left untreated, gingival diseases can progress to periodontal disease, a more serious condition that can result in tooth loss. Common types of gingival diseases include gingivitis and periodontitis.

Mouth diseases refer to a variety of conditions that affect the oral cavity, including the lips, gums, teeth, tongue, palate, and lining of the mouth. These diseases can be caused by bacteria, viruses, fungi, or other organisms. They can also result from injuries, chronic illnesses, or genetic factors.

Some common examples of mouth diseases include dental caries (cavities), periodontal disease (gum disease), oral herpes, candidiasis (thrush), lichen planus, and oral cancer. Symptoms may include pain, swelling, redness, bleeding, bad breath, difficulty swallowing or speaking, and changes in the appearance of the mouth or teeth. Treatment depends on the specific diagnosis and may involve medications, dental procedures, or lifestyle changes.

A fungal vaccine is a biological preparation that provides active acquired immunity against fungal infections. It contains one or more fungal antigens, which are substances that can stimulate an immune response, along with adjuvants to enhance the immune response. The goal of fungal vaccines is to protect against invasive fungal diseases, especially in individuals with weakened immune systems, such as those undergoing chemotherapy, organ transplantation, or HIV/AIDS treatment.

Fungal vaccines can work by inducing both humoral and cell-mediated immunity. Humoral immunity involves the production of antibodies that recognize and neutralize fungal antigens, while cell-mediated immunity involves the activation of T cells to directly attack infected cells.

Currently, there are no licensed fungal vaccines available for human use, although several candidates are in various stages of development and clinical trials. Some examples include vaccines against Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans, and Pneumocystis jirovecii.

Histoplasmosis is a pulmonary and systemic disease caused by the dimorphic fungus Histoplasma capsulatum. It is typically acquired through the inhalation of microconidia from contaminated soil, particularly in areas associated with bird or bat droppings. The infection can range from asymptomatic to severe, depending on factors like the individual's immune status and the quantity of inhaled spores.

In acute histoplasmosis, symptoms may include fever, cough, fatigue, chest pain, and headache. Chronic or disseminated forms of the disease can affect various organs, such as the liver, spleen, adrenal glands, and central nervous system, leading to more severe complications. Diagnosis often involves serological tests, cultures, or histopathological examination of tissue samples. Treatment depends on the severity and dissemination of the disease, with antifungal medications like itraconazole or amphotericin B being commonly used for moderate to severe cases.

An armadillo is not a medical condition or term. It is a type of mammal that is native to the Americas, known for its distinctive armor-like shell. If you have any questions about a specific medical condition or topic, I would be happy to help if you could provide more information.

I apologize, but "Brazil" is not a medical term or condition. It is the largest country in both South America and Latin America by land area and population. If you have any questions related to medical terminology or health concerns, please provide more information and I will do my best to help.

Mycology is the branch of biology that deals with the study of fungi, including their genetic and biochemical properties, their taxonomy and classification, their role in diseases and decomposition processes, and their potential uses in industry, agriculture, and medicine. It involves the examination and identification of various types of fungi, such as yeasts, molds, and mushrooms, and the investigation of their ecological relationships with other organisms and their environments. Mycologists may also study the medical and veterinary importance of fungi, including the diagnosis and treatment of fungal infections, as well as the development of antifungal drugs and vaccines.

Onygenales is a taxonomic order of fungi that includes several medically important genera that can cause various infections in humans and animals. The most well-known members of Onygenales are dermatophytes, which are the causative agents of superficial mycoses such as ringworm, athlete's foot, and jock itch. Other medically important genera in Onygenales include Histoplasma, Blastomyces, Coccidioides, and Paracoccidioides, which can cause systemic mycoses that affect the lungs and other organs.

The order Onygenales is characterized by the production of ascomata (sexual fruiting bodies) that are typically covered by a layer of hyphal cells called an ascostroma. The ascomata produce asci, which contain ascospores, the sexual spores of these fungi. Some members of Onygenales also produce asexual spores called conidia, which can be produced in various ways depending on the genus and species.

Overall, Onygenales is an important order of fungi that includes many pathogens with significant medical relevance.

Immunodiffusion is a laboratory technique used in immunology to detect and measure the presence of specific antibodies or antigens in a sample. It is based on the principle of diffusion, where molecules move from an area of high concentration to an area of low concentration until they reach equilibrium. In this technique, a sample containing an unknown quantity of antigen or antibody is placed in a gel or agar medium that contains a known quantity of antibody or antigen, respectively.

The two substances then diffuse towards each other and form a visible precipitate at the point where they meet and reach equivalence, which indicates the presence and quantity of the specific antigen or antibody in the sample. There are several types of immunodiffusion techniques, including radial immunodiffusion (RID) and double immunodiffusion (Ouchterlony technique). These techniques are widely used in diagnostic laboratories to identify and measure various antigens and antibodies, such as those found in infectious diseases, autoimmune disorders, and allergic reactions.

Mitosporic fungi, also known as asexual fungi or anamorphic fungi, are a group of fungi that produce mitospores (also called conidia) during their asexual reproduction. Mitospores are produced from the tip of specialized hyphae called conidiophores and are used for dispersal and survival of the fungi in various environments. These fungi do not have a sexual reproductive stage or it has not been observed, making their taxonomic classification challenging. They are commonly found in soil, decaying organic matter, and water, and some of them can cause diseases in humans, animals, and plants. Examples of mitosporic fungi include Aspergillus, Penicillium, and Fusarium species.

Coccidioidomycosis is a fungal infection caused by the inhalation of spores of the Coccidioides species, mainly C. immitis and C. posadasii. These fungi are commonly found in the soil of dry regions such as the southwestern United States, Mexico, and Central and South America.

The infection often begins when a person inhales the microscopic spores, which can lead to respiratory symptoms resembling a common cold or pneumonia. Some people may develop more severe symptoms, especially those with weakened immune systems. The infection can disseminate to other parts of the body, causing skin lesions, bone and joint inflammation, meningitis, or other complications in rare cases.

Diagnosis typically involves a combination of clinical evaluation, imaging studies, and laboratory tests such as fungal cultures, histopathological examination, or serological tests to detect antibodies against Coccidioides antigens. Treatment depends on the severity of the infection and the patient's immune status. Antifungal medications like fluconazole, itraconazole, or amphotericin B are commonly used for treating coccidioidomycosis. Preventive measures include avoiding inhaling dust in endemic areas, especially during excavation or construction activities.

... is caused by two species of fungi that can exist as a mold or yeast depending on temperature, P. ... Paracoccidioidomycosis (PCM), also known as South American blastomycosis, is a fungal infection that can occur as a mouth and ... Paracoccidioidomycosis is endemic in rural areas of Latin America, from southern Mexico to Argentina, and is also found in ... Travassos, Luiz R; Taborda, Carlos P; Colombo, Arnaldo L (April 2008). "Treatment options for paracoccidioidomycosis and new ...
Marques, Sílvio Alencar (1 November 2012). "Paracoccidioidomycosis". Clinics in Dermatology. 30 (6): 610-615. doi:10.1016/j. ... Cordova, LA; Torres, J (19 September 2022). "Paracoccidioidomycosis". StatPearls [Internet]. Treasure Island (FL). PMID ... as well as fungal infections such as paracoccidioidomycosis. Tumoral: Primary: Hodgkin lymphoma and non-Hodgkin lymphoma give ...
Paracoccidioidomycosis is more frequently seen in adult males than females. The hormone estrogen is thought to inhibit the ... 254 (1971). Paracoccidioidomycosis (1st ed.). Washington Pan American Health Organization. p. 325. Brummer E, Castaneda E, ... A number of serologic tests have been employed for the diagnosis of paracoccidioidomycosis. Double diffusion in agar gel and ... Paracoccidioides brasiliensis is a dimorphic fungus and one of the two species that cause paracoccidioidomycosis (the other ...
... is a dimorphic fungus that is one of the causal agents of paracoccidioidomycosis, together with ... Infection with the Paracoccidioides species, known as paracoccidioidomycosis, may be asymptomatic and subclinical, or may form ... Lacaz, CS; Franco (1994). "Historical evolution of the knowledge on paracoccidioidomycosis and its etiologic agent, ... Martinez, Roberto (September 2015). "Epidemiology of Paracoccidioidomycosis". Revista do Instituto de Medicina Tropical de São ...
Histoplasmosis Paracoccidioidomycosis Lamb, Vickie (2011). The Ultimate Hunting Dog Reference Book: A Comprehensive Guide to ...
"Parinaud'S oculoglandular syndrome associated with paracoccidioidomycosis". Rev. Inst. Med. Trop. Sao Paulo. 44 (1): 49-52. doi ...
Migliari DA, Sugaya NN, Mimura MA, Cucé LC (1998). "Periodontal aspects of the juvenile form of paracoccidioidomycosis". ...
This includes aspergillosis, blastomycosis, coccidioidomycosis, histoplasmosis, and paracoccidioidomycosis. It may be given by ...
"Abdominal alterations in disseminated paracoccidioidomycosis: computed tomography findings". Radiologia Brasileira. 48 (2): 81- ...
They include the causative agents of paracoccidioidomycosis and lobomycosis. Jiang Y, Dukik K, Munoz JF, Sigler L, Schwartz IS ...
... paracoccidioidomycosis, candidiasis Other granulomatous conditions; PR3+ vasculitis, Crohn's disease, acute granulomatous ...
October 2011). "Comparative genomic analysis of human fungal pathogens causing paracoccidioidomycosis". PLOS Genetics. 7 (10): ...
"Comparative Genomic Analysis of Human Fungal Pathogens Causing Paracoccidioidomycosis". PLOS Genetics. 7 (10): e1002345. doi: ...
... and paracoccidioidomycosis. Furthermore, persons with immuno-deficiencies are particularly susceptible to disease by genera ...
Vergara, ML; Martinez, R (1999). "Role of the armadillo Dasypus novemcinctus in the epidemiology of paracoccidioidomycosis". ...
Paracoccidioides brasiliensis and Paracoccidioides lutzii are the causal agents of paracoccidioidomycosis. Coccidioides immitis ...
Fungal infections, like paracoccidioidomycosis, trichophyton, or microsporum, are also possible infection causes. Trauma: Most ... Various fungal infections like paracoccidioidomycosis can cause lesions and changes in the hair locations of the eyelid. Trauma ...
"The pivotal role of 5-lipoxygenase-derived LTB4 in controlling pulmonary paracoccidioidomycosis". PLOS Neglected Tropical ...
There have also been rare case reports of paracoccidioidomycosis, zygomycosis and histoplasmosis infections causing genital ...
"Pulmonary paracoccidioidomycosis in AhR deficient hosts is severe and associated with defective Treg and Th22 responses". ...
... a worldwide causative agent of Paracoccidioidomycosis in dolphins. Azole antifungals are often used as a front-line therapy in ... "paracoccidioidomycosis ceti" in a Bottlenose Dolphin (Tursiops truncatus)". Mycopathologia. 182 (9-10): 937-946. doi:10.1007/ ...
... paracoccidioidomycosis, and talaromycosis infection. Histoplasmosis can also be diagnosed by a test for antibodies against ...
Endemic mycoses such as histoplasmosis, blastomycosis, coccidiomycosis and paracoccidioidomycosis can cause a fever of unknown ...
Her research work has focused mainly on mycoses (infections caused by fungi), emphasizing the study of Paracoccidioidomycosis ( ...
Paracoccidioidomycosis. Research groups also developed by Restrepo have begun studying two routes: the relationship between ...
... paracoccidioidomycosis, mycoses caused by Talaromyces marneffei and chromoblastomycosis; and prophylaxis of histoplasmosis and ...
... chromomycosis and paracoccidioidomycosis. First made in 1977, ketoconazole was the first orally-active azole antifungal ...
... in order of their psychological connection towards the object Paracoccidioidomycosis, an acute to chronic fungal infection r/ ...
... paracoccidioidomycosis) Sporotrichosis (rose-gardener's disease) Systemic candidiasis Tinea barbae (barber's itch, ringworm of ...
Some diseases caused by the fungi are: sporotrichosis blastomycosis histoplasmosis coccidioidomycosis paracoccidioidomycosis ...
Paracoccidioidomycosis is caused by two species of fungi that can exist as a mold or yeast depending on temperature, P. ... Paracoccidioidomycosis (PCM), also known as South American blastomycosis, is a fungal infection that can occur as a mouth and ... Paracoccidioidomycosis is endemic in rural areas of Latin America, from southern Mexico to Argentina, and is also found in ... Travassos, Luiz R; Taborda, Carlos P; Colombo, Arnaldo L (April 2008). "Treatment options for paracoccidioidomycosis and new ...
Paracoccidioidomycosis is an infection caused by the fungus Paracoccidioides. This fungus lives in parts of Central and South ... The symptoms of paracoccidioidomycosis can be different for different groups of people. 3,4 In adults, paracoccidioidomycosis ... Where Paracoccidioidomycosis Comes From. People get paracoccidioidomycosis after breathing in the fungus Paracoccidioides from ... How can I prevent paracoccidioidomycosis?. Its difficult to avoid breathing in the fungus that causes paracoccidioidomycosis ...
Paracoccidioidomycosis, formerly known as South American blastomycosis and Lutz-Splendore-Almeida disease, is a fungal ... encoded search term (Paracoccidioidomycosis) and Paracoccidioidomycosis What to Read Next on Medscape ... The 2 general clinical categories of paracoccidioidomycosis are (1) an acute/subacute form (juvenile paracoccidioidomycosis) ... The 2 general clinical categories of paracoccidioidomycosis are (1) an acute/subacute form (juvenile paracoccidioidomycosis) ...
Paracoccidioidomycosis, formerly known as South American blastomycosis and Lutz-Splendore-Almeida disease, is a fungal ... encoded search term (Paracoccidioidomycosis) and Paracoccidioidomycosis What to Read Next on Medscape ... The 2 general clinical categories of paracoccidioidomycosis are (1) an acute/subacute form (juvenile paracoccidioidomycosis) ... The 2 general clinical categories of paracoccidioidomycosis are (1) an acute/subacute form (juvenile paracoccidioidomycosis) ...
Intestinal and appendiceal paracoccidioidomycosis by: Gava,Priscila, et al. Published: (2015) * Anal paracoccidioidomycosis: an ... Intestinal paracoccidioidomycosis simulating colon cancer We report a case of intestinal involvement of Paracoccidioidomycosis ... Intestinal Paracoccidioidomycosis: Case report and systematic review by: Cruz,Eduarda Renz da, et al. Published: (2021) ... Prostatic paracoccidioidomycosis: differential diagnosis of prostate cancer by: Lopes,Daniel Lima, et al. Published: (2009) ...
The information contained in this website is of a general nature, is for informational purposes only and does not constitute professional advice ...
Paracoccidioidomycosis, formerly known as South American blastomycosis and Lutz-Splendore-Almeida disease, is a fungal ... encoded search term (Paracoccidioidomycosis) and Paracoccidioidomycosis What to Read Next on Medscape ... Paracoccidioidomycosis Medication. Updated: Mar 23, 2015 * Author: Duane R Hospenthal, MD, PhD, FACP, FIDSA, FASTMH; Chief ... Chronic paracoccidioidomycosis in a female patient in Austria. Eur J Clin Microbiol Infect Dis. 2004 Dec. 23(12):916-9. [QxMD ...
Paracoccidioidomycosis, formerly known as South American blastomycosis and Lutz-Splendore-Almeida disease, is a fungal ... encoded search term (Paracoccidioidomycosis) and Paracoccidioidomycosis What to Read Next on Medscape ... The 2 general clinical categories of paracoccidioidomycosis are (1) an acute/subacute form (juvenile paracoccidioidomycosis) ... The 2 general clinical categories of paracoccidioidomycosis are (1) an acute/subacute form (juvenile paracoccidioidomycosis) ...
Paracoccidioidomycosis - Learn about the causes, symptoms, diagnosis & treatment from the MSD Manuals - Medical Consumer ... Paracoccidioidomycosis, if it develops, usually resembles pneumonia Overview of Pneumonia Pneumonia is an infection of the ... Symptoms of Paracoccidioidomycosis Most people who inhale the spores develop an infection that causes no symptoms. Symptoms, if ... When paracoccidioidomycosis occurs in younger people or in people with HIV infection or AIDS, the infection is more aggressive ...
PEREIRA MACEDO, Mauricio et al. PARACOCCIDIOIDOMYCOSIS IN ORAL CAVITY- CASE REPORT. Odontol. Clín.-Cient. (Online) [online]. ... Palavras-chave : Diagnosis, Oral; Biopsy; Paracoccidioidomycosis. · resumo em Português · texto em Português · pdf em Português ... Paracoccidioidomycosis is a systemic fungal infection, primarily involving the lungs and may extend to other sites, including ... We report case of paracoccidioidomycosis, highlighting the importance of Hospital Dentistry for their diagnosis. Patient, 56, ...
In the hamster, Paracoccidioidomycosis develops as a chronic progressive disease and the lesions are related both to fungi and ... Disseminated paracoccidioidomycosis occurred in 100% of animals after day 5 of infection. Besides specific lesions (containing ... Experimental paracoccidioidomycosis in the syrian hamster: Morphology, ultrastructure and correlation of lesions with presence ... Iabuki, Kunie; Montenegro, Mario R.. Experimental paracoccidioidomycosis in the syrian hamster: Morphology, ultrastructure and ...
Paracoccidioidomycosis (PCM), caused by the fungus Paracoccidoides brasiliensis, is the most common endemic systemic mycosis in ... Paracoccidioidomycosis is the most common mycotic systemic disease in Latin America [2]. The patient reported in this case had ... Acute juvenile Paracoccidioidomycosis: a 9-year cohort study in the endemic area of Rio de Janeiro, Brazil. PLoS Negl Trop Dis ... Martinez R. Paracoccidioidomycosis: the dimension of the problem of a neglected disease. Rev Soc Bras Med Trop. 2010;43(4):480. ...
T-cell recognition of Paracoccidioides brasiliensis gp43-derived peptides in patients with paracoccidioidomycosis and healthy ... we selected and analyzed the T-cell responses of peripheral blood mononuclear cells from 29 paracoccidioidomycosis (PCM) ...
Pulmonary and cerebral paracoccidioidomycosis Images In Infectious Diseases. Machado, Matheus Garcia Lago; Rodrigues, Rosana ... Paracoccidioidomycosis as an opportunistic manifestation of acquired immunodeficiency syndrome Images In Infectious Diseases. ... Disseminated paracoccidioidomycosis with skull and mandible involvement in a heart transplant recipient Images In Infectious ...
Oral Paracoccidioidomycosis: A Case without Lung Manifestations By: Miguel Gustavo Setúbal Andrade, Alena Peixoto Medrado, Igor ...
Paracoccidioidomycosis. Mycobacterium marinum. Rhinoscleroma. Myiasis. Sarcoidosis. Sarcoidosis. Syphilis. Skin cancer. ...
... consistent with paracoccidioidomycosis infection, in whom a myeloperoxidase deficiency was later discovered. The treatment of ... Paracoccidioidomycosis is a systemic fungal infection that is potentially fatal, and the most prevalent of its kind in Latin ... Paracoccidioidomycosis is a systemic fungal infection that is potentially fatal, and the most prevalent of its kind in Latin ... Paracoccidioidomycosis is a systemic mycosis with an acute course, caused by the thermally dimorphic fungal complex ...
Paracoccidioidomycosis is a systemic disease caused by fungi of Paracoccidioides spp. , also of great importance in Brazil and ...
We present a patient who had MOP deficiency, who presented with a subacute form of paracoccidioidomycosis and later with ... Case report of myeloperoxidase deficiency associated with disseminated paracoccidioidomycosis and peritoneal tuberculosis Case ...
Diagnosis and Treatment of Pulmonary Coccidioidomycosis and Paracoccidioidomycosis. Peçanha-Pietrobom PM, Tirado-Sánchez A, ...
Categories: Paracoccidioidomycosis Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, ...
... paracoccidioidomycosis, Pickwickian syndrome, primary pulmonary hypertension, pulmonary embolism, pulmonary fibrosis, pulmonary ...
83 Coccidioidomycosis and Paracoccidioidomycosis. 84 Sporotrichosis. 85 Candidiasis and Rhodotorulosis. 86 Aspergillosis and ...
Paracoccidioidomycosis. * Fungi cause human infection when:. * Spores reach lung or paranasal sinus ...
Paracoccidioidomycosis * DECREASING PREVALENCE OF THE ACUTE/SUBACUTE CLINICAL FORM OF PARACOCCIDIOIDOMYCOSIS IN MATO GROSSO DO ...
Fungizone - Get up-to-date information on Fungizone side effects, uses, dosage, overdose, pregnancy, alcohol and more. Learn more about Fungizone
Experimental chemotherapy in paracoccidioidomycosis using ruthenium NO donor. Mycopathologia. 2011 Aug; 172(2):95-107. ...
The most common endemic mycoses are blastomycosis, coccidioidomycosis, histoplasmosis and paracoccidioidomycosis. The severity ...
  • Paracoccidioidomycosis (PCM), also known as South American blastomycosis, is a fungal infection that can occur as a mouth and skin type, lymphangitic type, multi-organ involvement type (particularly lungs), or mixed type. (wikipedia.org)
  • Paracoccidioidomycosis, formerly known as South American blastomycosis and Lutz-Splendore-Almeida disease, is a fungal infection endemic to South and Central America, most notably Brazil, Argentina, Colombia, and Venezuela (see the image below). (medscape.com)
  • The most common endemic mycoses are blastomycosis, coccidioidomycosis, histoplasmosis and paracoccidioidomycosis. (futurelearn.com)
  • Nizoral (ketoconazole) is an antifungal drug indicated for the treatment of the following fungal infections when alternatives are not available or not tolerated: blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. (fda.gov)
  • Paracoccidioidomycosis is caused by two species of fungi that can exist as a mold or yeast depending on temperature, P. brasiliensis and P. lutzii. (wikipedia.org)
  • Paracoccidioidomycosis is caused by the thermally dimorphic fungi of the genus Paracoccidioides . (medscape.com)
  • Paracoccidioidomycosis is caused by the thermally dimorphic fungi Paracoccidioides brasiliensis and P lutzii . (medscape.com)
  • Paracoccidioidomycosis (PCM) is a systemic mycosis caused by the dimorphic fungi Paracoccidioides brasiliensis (Pb) and Paracoccidioides lutzii [ 2 - 5 ]. (hindawi.com)
  • Paracoccidioidomycosis (PCM) is the most prevalent deep mycosis in Latin America and is caused by fungi from the Paracoccidioides genus. (bvsalud.org)
  • Paracoccidioidomycosis is a fungal infection endemic to South and Central America, most commonly Brazil, Argentina, Colombia, and Venezuela (see the image below). (medscape.com)
  • Paracoccidioidomycosis is a systemic fungal infection, primarily involving the lungs and may extend to other sites, including the mouth. (bvsalud.org)
  • Paracoccidioidomycosis is a systemic fungal infection that is potentially fatal, and the most prevalent of its kind in Latin America. (springeropen.com)
  • Paracoccidioidomycosis is a systemic fungal infection caused by Paracoccidiodes brasiliensis. (salientvisionarypub.com)
  • People get paracoccidioidomycosis after breathing in the fungus Paracoccidioides from the environment in certain parts of Central and South America. (cdc.gov)
  • Approximate distribution of paracoccidioidomycosis in North, Central, and South America, based on case reports. (medscape.com)
  • More than 15,000 cases of paracoccidioidomycosis have been recorded since 1930. (cdc.gov)
  • The antifungal drug itraconazole , given by mouth, is the treatment of choice for paracoccidioidomycosis. (msdmanuals.com)
  • The symptoms of paracoccidioidomycosis can be different for different groups of people. (cdc.gov)
  • Paracoccidioidomycosis can be treated with antifungal medicines such as itraconazole and amphotericin B. 7 Another medicine often used to treat paracoccidioidomycosis is trimethoprim/sulfamethoxazole (TMP/SMX), which is also known as co-trimoxazole and by several different brand names, including Bactrim, Septra, and Cotrim. (cdc.gov)
  • Healthcare providers use a patient's symptoms as well as laboratory tests and imaging tests, such as a chest X-ray, to diagnose paracoccidioidomycosis. (cdc.gov)
  • A blood test can also help diagnose paracoccidioidomycosis. (cdc.gov)
  • To diagnose paracoccidioidomycosis, a doctor takes tissue samples for examination under a microscope and for culture. (msdmanuals.com)
  • Intestinal Paracoccidioidomycosis: Case report and systematic review by: Cruz,Eduarda Renz da, et al. (sidalc.net)
  • We present an unusual case of intestinal paracoccidioidomycosis. (salientvisionarypub.com)
  • Mariana de Lira Fonte, Davi Viana Ramos, Eloy Vianey Carvalho de Franca, Amanda Lima Bruno, Alexandre de Sousa Carlos.Intestinal Paracoccidioidomycosis Mimicking Crohn's Disease: A Case Report. (salientvisionarypub.com)
  • Systemic antifungal medications are the mainstay of medical management in paracoccidioidomycosis. (medscape.com)
  • Antifungal medications are the mainstay of treatment for paracoccidioidomycosis. (medscape.com)
  • It is important to mention a recent study (Sampaio & Rivitti, 2008) in which blood samples of human patients with infectious dermatoses (Hansen´s disease, paracoccidioidomycosis) who lived in endemic areas of PF were searched for serum antibodies anti-DsG. (vin.com)
  • Paracoccidioidomycosis is an infection caused by the fungus Paracoccidioides . (cdc.gov)
  • It's difficult to avoid breathing in the fungus that causes paracoccidioidomycosis in areas where it's common in the environment. (cdc.gov)
  • The exact time between inhaling the fungus and getting paracoccidioidomycosis is not known, but scientists believe that many people are exposed to the fungus as children in areas where it's common in the environment. (cdc.gov)
  • Paracoccidioidomycosis is caused by inhaling spores of the fungus, which grow in soil. (msdmanuals.com)
  • Paracoccidioidomycosis (PCM), caused by the fungus Paracoccidoides brasiliensis , is the most common endemic systemic mycosis in Latin America. (clinicalcasereportsjournal.com)
  • Anyone who lives in or visits areas where Paracoccidioides lives can get paracoccidioidomycosis, but it most often affects men who work outdoors in rural areas. (cdc.gov)
  • By using a TEPITOPE algorithm, we selected and analyzed the T-cell responses of peripheral blood mononuclear cells from 29 paracoccidioidomycosis (PCM) patients to peptides of the immunodominant gp43 antigen of Paracoccidioides brasiliensis, the causative agent of PCM. (unifesp.br)
  • Paracoccidioidomycosis is a systemic mycosis with an acute course, caused by the thermally dimorphic fungal complex Paracoccidioides brasiliensis, which is present in wet zones of Latin America, where it is endemic. (springeropen.com)
  • Paracoccidoides brasiliensis and Paracoccidioides lutzii, the etiologic agents of paracoccidioidomycosis, cause disease in healthy and immunocompromised persons in Latin America. (bvsalud.org)
  • When paracoccidioidomycosis occurs in younger people or in people with HIV infection or AIDS, the infection is more aggressive. (msdmanuals.com)
  • We present a case of 48-year-old female patient with acute lymphoblastic leukemia, stem cell transplant candidate, who developed a fever with lymphadenopathy and lung nodules, consistent with paracoccidioidomycosis infection, in whom a myeloperoxidase deficiency was later discovered. (springeropen.com)
  • It's interesting to look at Paracoccidioidomycosis studies from South America, especially in young adults, an age groups that match crohn's disease unset. (crohnsforum.com)
  • The 2 general clinical categories of paracoccidioidomycosis are (1) an acute/subacute form (juvenile paracoccidioidomycosis) and (2) a chronic form (adult paracoccidioidomycosis). (medscape.com)
  • Paracoccidioidomycosis most commonly manifests as a chronic, progressive, systemic mycosis in men from the forested tropical and subtropical regions of Latin America. (medscape.com)
  • Some people with paracoccidioidomycosis develop a chronic lung disorder, which causes scarring (fibrosis) and widespread damage in the lungs (emphysema). (msdmanuals.com)
  • This case report presents a 53-year-old woman who expressed an uncommon form of chronic Paracoccidioidomycosis: oesophageal lesion causing progressive dysphagia. (clinicalcasereportsjournal.com)
  • It is also used for long-term maintenance or prophylaxis, for example 200 mg-400 mg daily for HIV-infected patients, 400 mg daily for patients suffering from chronic pulmonary aspergillosis, or 100 mg per day for more than one year for the treatment of paracoccidioidomycosis [ 1 ]. (ecancer.org)
  • The diagnosis of paracoccidioidomycosis is most commonly made by visualization of the yeast cells in tissue, wet preparations (eg, sputum), or superficial scrapings (eg, skin lesions). (medscape.com)
  • Prostatic paracoccidioidomycosis: differential diagnosis of prostate cancer by: Lopes,Daniel Lima, et al. (sidalc.net)
  • We report case of paracoccidioidomycosis, highlighting the importance of Hospital Dentistry for their diagnosis. (bvsalud.org)
  • It is known that P. brasiliensis and P. lutzii cause the paracoccidioidomycosis (PCM), which is characterized as systemic mycosis. (fapesp.br)
  • We report a case of intestinal involvement of Paracoccidioidomycosis, in a patient considered to have colonic cancer. (sidalc.net)
  • Bellissimo-Rodrigues F, Bollela VR, Da Fonseca BA, Martinez R. Endemic paracoccidioidomycosis: relationship between clinical presentation and patients' demographic features external icon . (cdc.gov)
  • Thus, the present study aims to evaluate the clinical association between the paracoccidioidomycosis and neoplasia. (ufrgs.br)
  • 1 , 2 For people who develop symptoms, paracoccidioidomycosis usually affects the lungs and skin. (cdc.gov)
  • 3 , 4 In adults, paracoccidioidomycosis usually affects the lungs and causes lesions in the mouth and throat. (cdc.gov)
  • Magnetic resonance image of the right wrist and forearm of patient with paracoccidioidomycosis, Brazil. (cdc.gov)
  • Polymorphism in the Promoter Region of the IL18 Gene and the Association With Severity on Paracoccidioidomycosis. (cdc.gov)
  • In patients with active paracoccidioidomycosis, chest radiography reveals interstitial infiltrates (in 64% of cases) or mixed lesions with linear and nodular infiltrates. (medscape.com)
  • Reports have documented successful treatment of paracoccidioidomycosis with voriconazole, posaconazole, and terbinafine. (medscape.com)
  • Scientists estimate that less than 5% of patients with paracoccidioidomycosis die from the disease. (cdc.gov)
  • Morejon KM, Machado AA, Martinez R. Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case-control study external icon . (cdc.gov)
  • Paracoccidioidomycosis, a key issue for Brazilian health service, can be aggravated in patients with impaired immunological responses, such as diabetic patients. (hindawi.com)
  • Patients with paracoccidioidomycosis may have comorbidities of non-infectious, such as Hodgkin's disease, leukaemia and cancers. (ufrgs.br)
  • Experimental chemotherapy in paracoccidioidomycosis using ruthenium NO donor. (harvard.edu)
  • Anal paracoccidioidomycosis: an unusual presentation of disseminated disease by: Vieira,René Aloisio da Costa, et al. (sidalc.net)
  • Paracoccidioidomycosis can occur in healthy people and people with weakened immune systems. (cdc.gov)
  • It is not considered the drug of choice in the treatment of paracoccidioidomycosis. (medscape.com)